Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch

Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Allergy and Clinical Immunology - Volume 137, Issue 4, April 2016, Pages 1258-1261.e10

Stacie M. MD, Wence K. PhD, David M. MD, A. Wesley MD, Robert D. MD, Michael W. MD, Laurent PharmD, Claude MD, Charles MS, Pierre-Henri MD,